Evidence map›Paper›PMID 39195445›Full record

ReviewMarine drugs2024

Genetic Engineering and Innovative Cultivation Strategies for Enhancing the Lutein Production in Microalgae.

Bert Coleman, Elke Vereecke, Katrijn Van Laere, Lucie Novoveska, Johan Robbens

Abstract readReview
In one paragraph

Review in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Microbial conversion of biodiesel waste for carotenoid production.Frontiers in bioengineering and biotechnology · 2026
    Article
  6. Harnessing microalgae for bioproducts: innovations in synthetic biology.World journal of microbiology & biotechnology · 2025
    Review
  7. Co-Culture ofMarine drugs · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bert ColemanAquatic Environment and Quality, Cell Blue Biotech and Food Integrity, Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), Jacobsenstraat 1, 8400 Ostend, Belgium.ORCID 0000-0002-5793-2808
Elke VereeckePlant Sciences Unit, Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), Caritasstraat 39, 9090 Melle, Belgium.
Katrijn Van LaerePlant Sciences Unit, Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), Caritasstraat 39, 9090 Melle, Belgium.ORCID 0000-0001-5398-5489
Lucie NovoveskaScotBio, Livingston EH54 5FD, UK.ORCID 0000-0002-5667-6769
Johan RobbensAquatic Environment and Quality, Cell Blue Biotech and Food Integrity, Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), Jacobsenstraat 1, 8400 Ostend, Belgium.

Funding

COST Ocean5Biotech CA18238European Union (Horizon 2020) project GeneBEcon 10106105Research Foundation Flanders 1SHGX24N
6 · The paper itself

Abstract

Carotenoids, with their diverse biological activities and potential pharmaceutical applications, have garnered significant attention as essential nutraceuticals. Microalgae, as natural producers of these bioactive compounds, offer a promising avenue for sustainable and cost-effective carotenoid production. Despite the ability to cultivate microalgae for its high-value carotenoids with health benefits, only astaxanthin and β-carotene are produced on a commercial scale by

Indexed as

Genetic EngineeringLuteinMicroalgaeAnimalsCarotenoidsHumansCarotenoidsLuteincarotenoidscultivation strategiesgenetic engineeringluteinmicroalgae

Identifiers

PMID39195445
PMCPMC11355070

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.